Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2014.353 | Performance of Fibrometer™ V in patients with chronic hepatitis B (HBV) | Prof. CHAN Henry Lik Yuen |
| 2017.197 | Kinetics of Hepatitis B core-related Antigen (HBcrAg) in Untreated and Nucleos(t)ide Analogue Treated Chronic Hepatitis B |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2015.622 | A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects with Chronic Hepatitis B Infection |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2015.703 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 in combination with Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects with Chronic Hepatitis B and who are currently not on Treatment |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2018.104 | A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of Treatment With Multiple Doses of JNJ-56136379 as Monotherapy and in Combination With a Nucleos(t)ide Analog in Subjects With Chronic Hepatitis B Virus Infection |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2016.190 | A Phase 2, Open-Label, Randomized Two-part, Multiple Dose Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected with Chronic Hepatitis B Virus |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2016.369 | Sample Collection for the Evaluation of Elecsys® PIVKA-II, AFP-L3 and AFP |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2016.350 | A Phase II/III, Open-label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-3682 + Grazoprevir + MK-8408 Fixed Dose Combination) in Subjects with Chronic Hepatitis C Virus GT5 or GT6 Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2018.313 | A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AB-506, an HBV Capsid Inhibitor, in Healthy Subjects and HBV-DNA Positive Subjects with Chronic HBV Infection |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2013.410 | A Phase 3b, Multicenter, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Sofosbuvir plus Ribavirin in Treatment-Na_ve Subjects with Chronic Genotype 1, 2, 3 and 6 HCV Infection and in Treatment-Experienced Subjects with Chronic Genotype 2 HCV Infection | Prof. CHAN Henry Lik Yuen |
| 2013.605 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After a Single Intravenous Dose of ARC-520 in Combination with Entecavir in Patients with Chronic Hepatitis B Virus (HBV) Infection, followed by a two-dose open label cohort and an open label single dose cohort in treatment naïve patients | Prof. CHAN Henry Lik Yuen |
| 2011.233 | A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon α-2a (Pegasys®) versus Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Non-Cirrhotic Subjects with HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B (CHB) | Prof. CHAN Henry Lik Yuen |
| 2010.336 | A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of FG-3019 in Subjects with Liver Fibrosis due to Chronic Hepatitis B Infection | Prof. CHAN Henry Lik Yuen |
| 2003.382 | A Randomized, Double-blind Trial of Telbivudine (LdT) versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis | Prof. CHAN Henry Lik Yuen |
| 2010.236 | Week 24 response and long-term outcomes of lamivudine (Zeffix) therapy in patients with chronic hepatitis B - A prospective cohort study | Professor Chan Henry |
| 2016.139 | Exploring moral distress and perceived constraints among nurses | Dr. CHAN Helen Yue Lai |
| 2022.496 | Effects of a decision support intervention on end-of-life care planning in patients with advanced chronic obstructive pulmonary disease and their family members: A mixed method approach | Prof. CHAN Helen Yue Lai |
| 2021.673 | A Multidisciplinary-led Personalised mHealth-supported Coach for Reducing Midlife Stroke Risk |
Prof CHAN Helen Yue Lai 陳裕麗 |
| 2023.616 | JC Brain Health: Jockey Club Dementia Screening and Community Support Project (DSCS) - Part 1. A two-arm pragmatic randomised controlled trial | Prof. CHAN Helen Yue Lai |
| 2022.594 | A HOme-based Psychoeducation programme to Empower spousal carers of older adults with frailty (HOPE) | Prof. CHAN Helen Yue Lai |
| 2017.099 | Promoting person-centred approach advance care planning in long-term care setting: A pilot study | Dr. CHAN Helen Yue Lai |
| 2017.019 | Training needs assessment of Nurse Preceptors in general hospital |
Dr. CHAN Helen Yue Lai 陳裕麗 |
| 2017.059 | Exploring the Experiences and Perceptions of Non-Invasive Ventilation among Patients with Chronic Obstructive Pulmonary Disease and Family Members: A Qualitative Study | Dr. CHAN Helen Yue Lai |
| 2017.414 | Effects of a Motivational-Interviewing-Tailored Programme for Promoting Advance Care Planning Behaviours on Patients with Palliative Care Needs: A Randomised Controlled Trial | Dr. CHAN Helen Yue Lai |
| 2024.341 | JC Brain Health: Jockey Club Dementia Screening and Community Support Project (DSCS) - Part 2. A waitlist randomised controlled trial | Prof. CHAN Helen Yue Lai |
| 2011.019 | The effect of 4 weeks Active Rest High-Intensity Interval Training (HIIT) vs Passive Rest HIIT on professional soccer players | Mr Chan Hardaway Chun-Kwan |
| 2013.120 | Identification of the novel gene mutation that causes a dominant spinocerebellar ataxia pedigree in Hong Kong | Prof. Chan H.Y. Edwin |
| 2019.324 | Effect of secondary hyperparathyroidism treatment on bone mineral density in peritoneal dialysis patients. |
Dr. CHAN Gordon Chun Kau 陳俊球 |
| 2018.587 | Progression of physical frailty in Chinese peritoneal dialysis patients |
Dr. CHAN Gordon Chun Kau 陳俊球 |
| 2020.091 | Incidence and predictive factors of peritonitis after gastrointestinal endoscopy in peritoneal dialysis patients. |
Dr. CHAN Gordon Chun Kau 陳俊球 |
| 2020.430 | Efficacy and safety of ticagrelor versus clopidogrel after acute myocardial infarction in peritoneal dialysis patients. |
Dr. CHAN Gordon Chun Kau 陳俊球 |
| 2019.715 | Association between frailty and bone mineral density in peritoneal dialysis patients. |
Dr. CHAN Gordon Chun Kau 陳俊球 |
| 2022.235 | Clinical outcomes of patients with hyponatremia and novel coronavirus infection (COVID-19), a territory wide cohort study. | Dr. CHAN Gordon Chun Kau |
| 2023.220 | Efficacy and safety of oral antiviral therapy in patients with chronic kidney disease diagnosed with novel coronavirus-2019 (COVID-19) infection. | Dr. CHAN Gordon Chun Kau |
| 2023.219 | The Efficacy and Safety of SGLT2 Inhibitor Therapy in Kidney Transplant Recipients | Dr. CHAN Gordon Chun Kau |
| 2013.262 | Risk perception in paranoid delusions and generalised anxiety disorder | Ms. CHAN Gloria Hoi Kei |
| 2019.042 | Obsessive and compulsive features in schizophrenia- A phenomenological investigation |
Ms. CHAN Gloria Hoi Kei 陳凱琪 |
| 2015.609 | The Effectiveness of wall stretching exercise of the heel cord to reduce metatarsalgia pain- a pilot study. |
Miss CHAN Gigi Wei Gi 陳蔚姿 |
| 2021.522 | Aveir Dual-Chamber Leadless i2i IDE Study |
Dr. CHAN Gary Chin Pang 陳展鵬 |
| 2016.696 | An Epidemiology Study of Out-Of-Hospital Sudden Cardiac Arrest and Sudden Death in Hong Kong |
Dr. CHAN Gary Chin Pang 陳展鵬 |
| 2014.577 | Ablation Observational Registry | Dr. CHAN Gary Chin Pang |
| 2012.370 | INGEVITY™ Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study | Dr. CHAN Gary Chin Pang |
| 2019.603 | Hong Kong WATCHMAN FLX™ Observation |
Dr. CHAN Gary Chin Pang 陳展鵬 |
| 2013.505 | Education workshop for "Expectant New Father" | Dr Chan Fung Ying |
| 2023.569 | Effects of Prefabricated Foot Orthoses with and without Metatarsal Pads in People with Central Metatarsalgia: A Randomized Controlled Trial |
Ms. CHAN Fung Ting 陳鳳婷 |
| 2013.356 | A clinical control study - The effect of 8-week aerobic kickboxing exercise for substance abstinence, relapse prevention and improvement of substance-related physical, mental and cognitive impairement. | Associate Consultant Chan Fu |
| 2018.156 | Substance misuse To Psychosis for Stimulants (SToP-S)—An Early Assertive Pharmacotherapy Intervention Study |
Dr. CHAN Fu 陳虎 |
| 2012.010 | Elucidating the role of nuclear receptor Tailless/TLX in cellular senescence in prostate cancer | Prof. CHAN Franky Leung |
| 2009.173 | Functional Role of Estrogen-related Receptor Alpha in Prostate Cancer | Prof. CHAN Franky Leung |
| 2013.322 | Elucidating the functional role of nuclear receptor NR4A2 in acquired apoptosis-resistant growth in castration-resistant prostate cancer | Prof. CHAN Franky Leung |
Page 199 of 254.